发明名称 |
Self-organized vascular networks from human pluripotent stem cells in a synthetic matrix |
摘要 |
A bicellular vascular population derived from human pluripotent stem cells (hPSCs) undergoes morphogenesis and assembly in a synthetic hydrogel. It is shown that hPSCs can be induced to co-differentiate into early vascular cells (EVCs) in a clinically-relevant strategy dependent upon Notch activation. These EVCs mature into ECs and pericytes, and self-organize to form vascular networks in an engineered matrix. Upon in vivo implantation, multicellular human vascular networks are functionally perfused. Thus, a derived bicellular population is exploited for its intrinsic self-assembly capability to create functional microvasculature in a deliverable matrix. |
申请公布号 |
US9506037(B2) |
申请公布日期 |
2016.11.29 |
申请号 |
US201313844313 |
申请日期 |
2013.03.15 |
申请人 |
THE JOHNS HOPKINS UNIVERSITY |
发明人 |
Gerecht Sharon;Kusuma Sravanti |
分类号 |
C12N5/00;C12N5/02;A61K38/17;C07K14/00;C12N5/071 |
主分类号 |
C12N5/00 |
代理机构 |
Johna Hopkins Tech Ventures |
代理人 |
Johna Hopkins Tech Ventures |
主权项 |
1. A method for differentiating human embryonic stem cells (hESCs) or human induced pluripotent stem cells (hiPSCs) into early vascular cells (EVCs) in vitro, comprising the steps of:
plating a single-cell suspension of hESCs or hiPSCs onto a surface coated with suitable materials selected from the group consisting of type I collagen, fibronectin, and type IV collagen; adding culture medium; culturing the cells for several days; adding Vascular Endothelial Growth Factor (VEGF) and a transforming growth factor-beta (TGF-β) inhibitor to the culture medium; culturing the cells for several days; and harvesting the resulting EVCs, wherein said EVCs express CD73 and one or more of CD105 and CD146. |
地址 |
Baltimore MD US |